Back to Results
First PageMeta Content
Pharmacology / Committee for Medicinal Products for Human Use / Directive 2001/83/EC / International System of Units / International relations / Health / Measurement / Pharmaceuticals policy / Clinical research / Medicinal product


Microsoft Worddoc
Add to Reading List

Document Date: 2007-02-25 20:37:12

Open Document

File Size: 197,62 KB

Share Result on Facebook

City

Tablet / /

Company

N.A. 50 N.A. / CHMP 2006 535 219 104 N.A. / N.A. 2 N.A. / N.A. 115 N.A. / REFERRED TO 10 N.A. / A. 1 N.A. / /

Country

Germany / Romania / Bulgaria / United Kingdom / /

/

/

IndustryTerm

individual products / repeat use applications / hybrid applications / active substance applications / bibliographic applications / treatment of Parkinson’s disease / category products / line extension applications / pharmaceutical forms / medicinal product / pergolide products / chemical substance applications / medicinal products / orphan medicinal products / /

MedicalCondition

recurrent infections / CMD / Parkinson’s disease / MS / Complicated urinary tract infections / indication Parkinson’s disease / /

Organization

Pharmacovigilance Working Party / Interested Party / European Union / /

Person

Truus Janse-de Hoog / /

/

Position

chair / representative / /

Product

finasteride / Opratifi 50mg opipramol Coated tablet / cabergoline / EL / ES / Fentanyl / Ciprofloxacin / /

ProgrammingLanguage

EC / /

ProvinceOrState

Mississippi / /

PublishedMedium

the European / /

Technology

MRI / /

URL

http /

SocialTag